Table 3

ORs ofHPV positivity and corresponding 95% CIs according to selected characteristics among 138 HIV-positive womena. Santos, São Paulo, Brazil, 1996–1997

Cervical+Vaginal

Cervical+Analb

Vaginal+Analb

Cervical+Vaginal+Analb


Tot. No

Pos. (%)

ORc

95% CI

Tot. No

Pos. (%)

ORc

95% CI

Tot. No

Pos. (%)

ORc

95% CI

Tot. No

Pos. (%)

ORc

95% CI


Age (years)

≥ 35

39

38.5

1

30

10.0

1

30

13.3

1

30

6.7

1

25–34

75

49.3

1.6

0.7–3.4

55

27.3

3.4

0.9–12.8

55

34.6

3.4

1.0–11.3

55

27.3

5.3

1.1–24.8

< 25

24

58.3

2.2

0.8–6.3

17

47.1

8.0

1.7–36.8

17

41.2

4.6

1.1–19.0

17

35.3

7.6

1.3–43.8

p for trend

0.12

0.006

0.03

0.02

Tobacco smoking

Never smoker

44

45.5

1

32

31.3

1

32

31.3

1

32

21.9

1

Ex-smoker

33

45.5

1.1

0.4–2.8

26

30.8

1.1

0.3–3.8

26

34.6

1.2

0.4–3.7

26

30.8

1.7

0.5–6.1

Current smoker

61

50.8

1.3

0.6–3.0

44

18.2

0.5

0.2–1.7

44

25.0

0.8

0.3–2.2

44

18.2

0.9

0.3–2.9

p for trend

0.46

0.22

0.52

0.60

Drug addict

Never

79

45.6

1

62

25.8

1

62

25.8

1

62

21.0

1

Ex

36

52.8

1.3

0.6–2.8

24

29.2

1.1

0.4–3.2

24

45.8

2.2

0.8–6.2

24

29.2

1.4

0.5–4.2

Current

23

47.8

1.0

0.4–2.7

16

18.8

0.7

0.2–2.9

16

18.8

0.6

0.2–2.6

16

18.8

0.8

0.2–3.5

p for trend

0.80

0.70

0.99

0.98

Years since HIV diagnosis

≤ 1

54

46.3

1

40

27.5

1

40

32.5

1

40

22.5

1

2–4

43

39.5

0.8

0.4–1.9

34

60.529.4

1.3

0.4–3.8

34

32.4

1.0

0.4–2.8

34

26.5

1.3

0.4–4.2

≥ 5

39

56.4

1.8

0.7–4.2

26

19.2

0.7

0.2–2.8

26

23.1

0.5

0.2–1.9

26

19.2

0.8

0.2–3.1

p for trend

0.25

0.73

0.38

0.81

CD4 count/mm3

≥ 500

34

41.2

1

20

15.0

1

20

15.0

1

20

10.0

1

200–499

51

49.0

1.8

0.7–4.7

39

23.1

4.2

0.8–22.2

39

30.8

4.8

1.0–22.7

39

23.1

5.7

0.9–34.1

< 200

53

59.9

1.8

0.7–4.6

43

32.6

5.9

1.2–28.6

43

34.9

5.0

1.1–22.4

43

27.9

6.2

1.1–34.9

p for trend

0.24

0.03

0.06

0.06

Commercial sex worker

Never

107

46.7

1

82

24.4

1

82

26.8

1

82

20.7

1

Ever

31

51.6

1.2

0.5–2.6

20

30.0

1.2

0.4–3.8

20

40.0

1.7

0.6–4.8

20

30.0

1.5

0.5–4.6

Lifetime number of sexual partners

≤ 2

34

41.2

1

26

26.9

1

26

30.8

1

26

26.9

1

3–5

44

52.3

1.5

0.6–3.8

35

25.7

0.9

0.3–2.9

35

25.7

0.7

0.2–2.3

35

17.1

0.5

0.1–1.8

≥ 6

60

48.3

1.2

0.5–3.0

41

24.4

0.7

0.2–2.3

41

31.7

0.8

0.3–2.6

41

24.4

0.7

0.2–2.2

p for trend

0.63

0.32

0.85

0.53

Recent sexual partnersd

0

48

43.8

1

42

21.4

1

42

26.2

1

42

21.4

1

1

74

47.3

1.0

0.5–2.1

51

25.5

0.8

0.3–2.4

51

27.5

0.8

0.3–2.0

51

19.6

0.6

0.2–1.7

≥ 2

13

76.9

3.5

0.8–15.0

9

44.4

2.2

0.5–10.7

9

55.6

2.6

0.5–12.0

9

44.4

2.0

0.4–9.5

p for trend

0.21

0.56

0.52

0.83

Condom used

Yes

69

47.8

1

47

25.5

1

47

27.7

1

47

19.2

1

No

20

60.0

1.7

0.6–4.8

13

38.5

2.0

0.5–7.6

13

46.2

2.4

0.7–8.8

13

38.5

2.9

0.7–11.6

Anal intercourse

Never

66

48.5

1

51

19.6

1

51

19.6

1

51

19.6

1

Ever

72

47.2

0.9

0.5–1.8

51

31.4

1.7

0.6–4.3

51

39.2

2.4

0.97–6.0

51

25.5

1.2

0.5–3.2


aSome figures do not add up to the total due to missing values; bPresented for 102 HIV-positive women; cAdjusted for age. HPV = human papillomavirus; d relative to the last 6 months preceding interview; HIV = human immunodeficiency virus; OR = odds ratio; CI = confidence intervals.

Gonçalves et al. Infectious Agents and Cancer 2008 3:5   doi:10.1186/1750-9378-3-5

Open Data